Pharma Value at the 3rd GIRF Congress - ISPOR Group Rome for Future
On 19 and 20 June, the 3rd National Congress of the Ispor Roma for Future GIRF group was held in Bologna, confirming its role
21 June 2024
On 19 and 20 June, the 3rd National Congress of the Ispor Roma for Future GIRF group was held in Bologna, confirming its role
The National Commission for Updating the Essential Levels of Care (Livelli Essenziali di Assistenza - LEA) was renewed by Ministerial Decree of 18/03/2024. The President of the Commission is the Minister
Our Easter greeting this year is multi-voiced. Each person in the team wanted to share their thoughts on Easter, in the idea of participation
A year has already passed since 17 February 2023, when, defying superstition and low immune defences, Pharma Value decided to grow from a company
On 14 February 2024 in Rome, at the Capranichetta Hall of the Hotel Nazionale, the presentation of 'Basta essere Pazienti', OMAR's campaign in
Pharma Value has developed a Comparison of Marketing Authorisations Issued by the FDA and EMA in 2023. The aim of the analysis is to provide a
The analysis addresses differences in regional access times for drug reimbursement in Italy. Following the official publication for drug reimbursement in the Gazzetta Ufficiale, the
The poster addresses the evolution of the utilisation of the AIFA 5% Fund, established in 2003 for the acquisition of orphan drugs and the treatment
Pharma Value will participate in ISPOR Europe 2023, which will be held from 12 to 15 November 2023 in Copenhagen. Flying to Denmark will be Ginevra Mastroianni, Institutional and
On 31 October 2023, the 'stamped' text of the Budget Law 2024 arrived in Parliament for the final approval process. Pharma Value analysed
